China Resources Pharmaceutical Group Ltd.(HK:3320)
HK$4.54-0.08 (-1.84%)
HK:3320
China Resources Pharmaceutical Group Ltd. financials statements
HK$4.54
At close:-0.08 (-1.84%)
Want to see HK:3320 full AI Analyst Report?
China Resources Pharmaceutical Group Ltd. (3320) Financial Statements
4 Followers
China Resources Pharmaceutical Group Ltd. Financial Overview
China Resources Pharmaceutical Group Ltd.'s market cap is currently ¥29.06B. The company's EPS TTM is ¥0.75; its P/E ratio is 6.11; and it has a dividend yield of 5.28%. China Resources Pharmaceutical Group Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 300.01B | ¥ 274.18B | ¥ 270.40B | ¥ 223.13B | ¥ 193.24B |
| Gross Profit | ¥ 49.53B | ¥ 43.30B | ¥ 42.43B | ¥ 34.36B | ¥ 28.87B |
| Operating Income | ¥ 13.90B | ¥ 12.56B | ¥ 13.90B | ¥ 9.49B | ¥ 7.55B |
| EBITDA | ¥ 18.55B | ¥ 16.36B | ¥ 15.34B | ¥ 13.59B | ¥ 9.79B |
| Net Income | ¥ 4.50B | ¥ 3.57B | ¥ 4.24B | ¥ 3.64B | ¥ 3.08B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 31.05B | ¥ 27.28B | ¥ 35.46B | ¥ 28.56B | ¥ 30.45B |
| Total Assets | ¥ 318.34B | ¥ 274.28B | ¥ 271.48B | ¥ 214.19B | ¥ 202.83B |
| Total Debt | ¥ 104.87B | ¥ 73.43B | ¥ 62.16B | ¥ 56.06B | ¥ 55.45B |
| Net Debt | ¥ 87.24B | ¥ 55.95B | ¥ 35.04B | ¥ 34.89B | ¥ 34.79B |
| Total Liabilities | ¥ 187.52B | ¥ 169.90B | ¥ 169.20B | ¥ 134.14B | ¥ 125.57B |
| Stockholders' Equity | ¥ 57.26B | ¥ 51.34B | ¥ 50.60B | ¥ 43.52B | ¥ 41.60B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 18.83B | ¥ 14.55B | ¥ 12.42B | ¥ 6.62B | ¥ 6.79B |
| Operating Cash Flow | ¥ 22.78B | ¥ 18.65B | ¥ 15.55B | ¥ 9.57B | ¥ 9.16B |
| Investing Cash Flow | ¥ -11.20B | ¥ -9.45B | ¥ -2.07B | ¥ -2.90B | ¥ -7.21B |
| Financing Cash Flow | ¥ -12.19B | ¥ -17.91B | ¥ -4.07B | ¥ -7.90B | ¥ 4.34B |
Currency in CNY
